Description

CJC-1295 with DAC works by binding to GHRH receptors in the pituitary gland, which stimulates the release of growth hormone in a sustained manner. The DAC modification allows the peptide to attach to albumin in the bloodstream, extending its activity and allowing it to remain active for several days rather than hours.

This prolonged stimulation can lead to increased growth hormone and IGF-1 levels, which are associated with improvements in fat metabolism, muscle development, recovery, and overall body composition. Because of its long half-life and sustained GH stimulation, CJC-1295 with DAC is often described as a long-acting growth hormone–releasing peptide used to support metabolic function, recovery, and tissue repair.